NM_001009944.3:c.4665A>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001009944.3(PKD1):​c.4665A>C​(p.Ala1555Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 1,612,016 control chromosomes in the GnomAD database, including 30,363 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1555A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.25 ( 6671 hom., cov: 34)
Exomes 𝑓: 0.17 ( 23692 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.74

Publications

22 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 16-2110502-T-G is Benign according to our data. Variant chr16-2110502-T-G is described in ClinVar as Benign. ClinVar VariationId is 256968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.74 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.483 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001009944.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD1
NM_001009944.3
MANE Select
c.4665A>Cp.Ala1555Ala
synonymous
Exon 15 of 46NP_001009944.3P98161-1
PKD1
NM_000296.4
c.4665A>Cp.Ala1555Ala
synonymous
Exon 15 of 46NP_000287.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD1
ENST00000262304.9
TSL:1 MANE Select
c.4665A>Cp.Ala1555Ala
synonymous
Exon 15 of 46ENSP00000262304.4P98161-1
PKD1
ENST00000423118.5
TSL:1
c.4665A>Cp.Ala1555Ala
synonymous
Exon 15 of 46ENSP00000399501.1P98161-3
PKD1
ENST00000488185.2
TSL:5
c.471-2144A>C
intron
N/AENSP00000456672.1H3BSE9

Frequencies

GnomAD3 genomes
AF:
0.252
AC:
38340
AN:
152084
Hom.:
6649
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.488
Gnomad AMI
AF:
0.134
Gnomad AMR
AF:
0.186
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0882
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.166
Gnomad OTH
AF:
0.246
GnomAD2 exomes
AF:
0.164
AC:
40642
AN:
248566
AF XY:
0.158
show subpopulations
Gnomad AFR exome
AF:
0.502
Gnomad AMR exome
AF:
0.112
Gnomad ASJ exome
AF:
0.233
Gnomad EAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.186
Gnomad NFE exome
AF:
0.167
Gnomad OTH exome
AF:
0.178
GnomAD4 exome
AF:
0.168
AC:
244989
AN:
1459814
Hom.:
23692
Cov.:
37
AF XY:
0.165
AC XY:
119809
AN XY:
726224
show subpopulations
African (AFR)
AF:
0.503
AC:
16824
AN:
33454
American (AMR)
AF:
0.121
AC:
5397
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.239
AC:
6237
AN:
26118
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39698
South Asian (SAS)
AF:
0.0900
AC:
7763
AN:
86232
European-Finnish (FIN)
AF:
0.183
AC:
9517
AN:
51874
Middle Eastern (MID)
AF:
0.236
AC:
1329
AN:
5622
European-Non Finnish (NFE)
AF:
0.168
AC:
187024
AN:
1111770
Other (OTH)
AF:
0.180
AC:
10887
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
13965
27929
41894
55858
69823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6720
13440
20160
26880
33600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.252
AC:
38409
AN:
152202
Hom.:
6671
Cov.:
34
AF XY:
0.248
AC XY:
18421
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.489
AC:
20294
AN:
41508
American (AMR)
AF:
0.185
AC:
2835
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
817
AN:
3468
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5190
South Asian (SAS)
AF:
0.0878
AC:
424
AN:
4828
European-Finnish (FIN)
AF:
0.191
AC:
2032
AN:
10612
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.166
AC:
11293
AN:
67980
Other (OTH)
AF:
0.244
AC:
515
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1360
2720
4080
5440
6800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
696
Bravo
AF:
0.264
Asia WGS
AF:
0.0770
AC:
269
AN:
3478
EpiCase
AF:
0.179
EpiControl
AF:
0.177

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Autosomal dominant polycystic kidney disease (1)
-
-
1
Polycystic kidney disease (1)
-
-
1
Polycystic kidney disease, adult type (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.8
DANN
Benign
0.67
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71385734; hg19: chr16-2160503; COSMIC: COSV51916428; COSMIC: COSV51916428; API